2021 CMSC Annual Meeting

Tag: 7313DMT64Poster-Disease-modifying TherapySmathorn Thakolwiboon

Poster-Disease-modifying Therapy

The Benefits of Azathioprine in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: A Systematic Review and Meta-Analysis

Background: MOGAD is an emerging inflammatory demyelination disorder of the central nervous system. AZA is one of the commonly used...

Read More